Laboratory Result

Name: R. GOOPIO Chief Complaint: VAGINAL BLEEDING

Age: 31 yrs old Diagnosis: TO CONSIDER THREATENED ABORTION
LABORATORY TEST NORMAL VALUE RESULT IMPLICATION NURSING CONSIDERATION
CBC

RBC 4.00-5.00 x 10^12/L 3.83 g/dL May indicate anemia Encourage to increase iron in the
diet
Administer Iron Supplements as
ordered

0.37-0.47 0.35 May indicate anemia Encourage to increase iron in the

HEMATOCRIT diet
Administer Iron Supplements as
ordered

DIFFERENTIAL COUNT

Lymphocytes 20.00-40.00 18.00 May indicate lymphopenia

Eosinophils 0.00-5.00 6.00 May indicate eosinophilia

Monocytes 0.00-7.00 8.00 May indicate monocytosis

HCG POSITIVE PREGNANT

 DRUG STUDY

Patient:R. GOOPIO Diagnosis: TO CONSIDER THREATENED ABORTION

Age: 31 years old Physician: Dr. Gilda Roise B. Lim, MD
Ward: GYNE
NAME OF DRUG CLASSIFICATION MECHANISM OF INDICATION ADVERSE EFFECTS NURSING PATIENT TEACHING
ACTION CONSIDERATION
Inhibits cell-wall Serious lower CV: phlebitis, • Monitor patient for • Tell patient to take
synthesis, promoting respiratory tract thrombophlebitis. signs and symptoms drug as prescribed,
Generic Antibiotics osmotic instability; infection, UTI, skin or GI: diarrhea, of superinfection and even if feeling better.
cefuroxime sodium Second-generation usually bactericidal. skin-structure pseudomembranous diarrhea and treat • Advise patient who
cephalosporins infections, bone or colitis, nausea, appropriately. has difficulty
joint infection, anorexia, vomiting. • Drug may increase swallowing tablets to
Brand septicemia, Hematologic: hemolytic INR and risk of ask prescriber for the
Zinacef meningitis, and anemia, bleeding. Monitor suspension.
gonorrhoea. Adults thrombocytopenia, patient. • Tell parent to shake
Dosage and children age 13 transient neutropenia, • Look alike–sound suspension well
750 mg and older: 750 mg to eosinophilia. alike: Don't confuse before measuring
1.5 g cefuroxime Skin: maculopapular drug with other dose. Suspension may
Route of sodium IV or IM every and erythematous cephalosporins that be stored at room
Administration 8 hours for 5 to 10 rashes, urticaria, pain, sound alike. temperature or
IV days. For life- induration, sterile refrigerated, but must
threatening infections abscesses, temperature be discarded after 10
and infections caused elevation, tissue days.
Frequency by less susceptible sloughing at IM • Instruct caregiver to
Q8hours organisms, 1.5 g IV or injection site. give oral suspension
Timing IM every 6 hours; for Other: anaphylaxis, with food.
6am, 2pm 10pm bacterial meningitis, hypersensitivity • Instruct patient to
up to 3 g IV every 8 reactions, serum notify prescriber
hours. Children ages 3 sickness. about rash, loose
months to 12 years: stools, diarrhea, or
50 to 100 mg/kg/day evidence of
cefuroxime sodium IV superinfection.
 or IM in equally • Advise patient
divided doses every 6 receiving drug IV to
to 8 hours. Use higher report discomfort at
dosage of 100 IV insertion site.
mg/kg/day, not to
exceed maximum
adult dosage, for
more severe or
serious infections. For
bacterial meningitis,
200 to 240 mg/kg/day
cefuroxime sodium IV
in divided doses every
6 to 8 hours

Generic peripheral Isoxsuprine, a β- Cerebrovascular and Significant: severe rash >Obtain a thorough >Provide clear and
isoxsuprine vasodilators agonist, increases peripheral vascular Nervous: trembling, patient history, comprehensive
muscle blood flow by disease. Adult: 10-20 nervousness, including any known education to the
directly relaxing the mg 3 or 4 time a day weakness, dizziness. allergies to patient about the
Brand vascular smooth CV: palpitation, medications. purpose of
muscle tachycardia, chest pain, >Assess the patient's isoxsuprine and its
Dosage hypotension, flushing current medical potential benefits.
10 mg GI: abdominal distress, condition, including >Instruct the patient
nausea, vomiting, cardiovascular status, on the proper
Route of intestinal distention. blood pressure, and administration of the
Administration heart rate. medication, including
ORAL >Evaluate the dosage, frequency,
patient's obstetric and any specific
history and the reason instructions (e.g., take
Frequency for prescribing with food).
TID isoxsuprine. >Emphasize the
 importance of
compliance with the
Timing prescribed regimen.
6am, 2pm 10pm

>Inform patient about

Generic Pharmacologic: An essential mineral Prevention and CNS: seizures, dizziness, >monitor blood what possible adverse
Multivitamins + FeSO Water-soluble found in haemoglobin, treatment of iron- headaches, syncope studies of patient effects that may occur
vitamins, iron myoglobin, and many vitamin and dietary CV: hypotension, >observe proper >inform patient about
supplements enzymes. Enters the deficiency anemias; hypertension, dosage of medication what dark, green or
Brand bloodstream and is used in anemia due to tachycardia >note other drugs black stools to avoid
Mulvitron Therapeutic: Vitamins transported to the blood loss dring GI: nausea, patient is taking to panic
& minerals organs of the menstruatin, constipation, dark avoid possible
antianemics reticuloendothelial infections, surgery, stools, diarrhea, interactions
Dosage system (liver, spleen, delivery, intoxications, vomiting
1 cap bone marrow), where parasitosis, or other Dermatologic: flushing,
it is separated out and causes & anemias urticarial
becomes part of iron during pregnancy Respiratory: cough,
Route of stores. dyspnea
Administration MS: arthralgia, myalgia
ORAL Local: pain at IM site
Others: staining of
teeth, anaphylaxis,
Frequency sweating
OD

Timing
6am
MV + FeSO4 Drug Study | PDF | Anemia | Dose (Biochemistry) (scribd.com)

https://www.mims.com/philippines/drug/info/isoxsuprine?mtype=generic